Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China
· Delayed Price · Currency is CNY 98.59
+2.99 (3.13%)
May 30, 2025, 11:30 AM CST
SHA:688578 Revenue
Shanghai Allist Pharmaceuticals had revenue of 1.10B CNY in the quarter ending March 31, 2025, with 47.86% growth. This brings the company's revenue in the last twelve months to 3.91B, up 57.51% year-over-year. In the year 2024, Shanghai Allist Pharmaceuticals had annual revenue of 3.56B with 76.29% growth.
Revenue (ttm)
3.91B
Revenue Growth
+57.51%
P/S Ratio
10.99
Revenue / Employee
3.75M
Employees
1,044
Market Cap
43.02B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |